HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Diabetes & Endocrinology
RCT
Liraglutide reduces OSA severity in patients with COPD and obesity in exploratory analysis
Could a weight loss drug help people with COPD breathe easier at night?
A secondary exploratory analysis of a 40-week RCT in 40 patients with COPD and overweight/obesity found liraglutide (3.0 mg) significantly r…
A weight loss drug reduced breathing pauses and oxygen drops for people with COPD and sleep apnea, improving general health while day-time s…
Apr 8, 2026
Allergy & Immunology
Sys. Review
Systematic review finds moderate to substantial concordance among fungal sIgE detection kits for asthma
Review finds variation in tests for fungal allergy in asthma patients
A systematic review of 16 human studies evaluating 32 commercial fungal sIgE detection kits found moderate to substantial concordance with t…
Asthma fungal allergy tests often give different results because commercial kits use different methods and cut-off points, making it hard to…
Frontiers
Apr 8, 2026
Pulmonology & Critical Care
Genetic analysis links oral microbiota to COPD risk in East Asian population
Could the bacteria in your mouth affect your risk of COPD?
A genetic causal inference and bioinformatics analysis using East Asian GWAS data identified 48 oral microbial taxa associated with COPD ris…
A study in East Asian people links 48 types of mouth bacteria to COPD risk and identifies a gene and six existing drugs that might target it…
medRxiv
Apr 8, 2026
Pulmonology & Critical Care
FDA Approval
FDA Approves Nintedanib Capsules (nintedanib esylate) for Idiopathic Pulmonary Fibrosis and Progressive Fibrosing ILDs
FDA approves a new drug to treat two types of progressive, scarring lung diseases
The FDA has approved nintedanib capsules for the treatment of adults with idiopathic pulmonary fibrosis (IPF) and for adults with chronic fi…
FDA approves new drug to treat two types of progressive, scarring lung diseases that make lungs stiff and hard to breathe.
FDA
Apr 7, 2026
Pulmonology & Critical Care
FDA Approval
FDA Approves Nintedanib Capsules (nintedanib esylate) for Idiopathic Pulmonary Fibrosis and Progressive Fibrosing ILDs
FDA approves a new drug to treat two serious, scarring lung diseases in adults
The FDA has approved nintedanib capsules for the treatment of adults with idiopathic pulmonary fibrosis (IPF) and for adults with chronic fi…
FDA approves new drug nintedanib to treat two serious, scarring lung diseases in adults with progressive conditions.
FDA
Apr 7, 2026
Rheumatology
Meta-analysis
Rheumatoid arthritis is associated with a 58% higher risk of COPD compared to the general population
Rheumatoid Arthritis Patients Face Higher Risk of Developing Chronic Lung Disease
This systematic review and meta-analysis evaluated 1,710,600 individuals to assess the prevalence and risk of chronic obstructive pulmonary …
People with rheumatoid arthritis face a significantly higher risk of developing chronic obstructive pulmonary disease compared to the genera…
NEJM
Apr 6, 2026
Allergy & Immunology
RCT
Phase 1 trial finds inhaled JAK1 inhibitor londamocitinib reduces Feno in mild asthma
Can a new inhaled asthma drug calm lung inflammation? Early trial shows promise
This first-in-human, phase 1 randomized controlled trial in 85 healthy volunteers and 18 participants with mild asthma found inhaled londamo…
A new inhaled asthma drug cut a key lung inflammation marker by half in early human testing, showing promise for calming the quiet battle in…
Apr 6, 2026
Pulmonology & Critical Care
Meta-analysis
Systematic review of Traditional Chinese Exercise shows improved function and well-being in 2434 COPD patients
Traditional Chinese Exercise May Improve Function and Well-being in COPD Patients
This systematic review and meta-analysis of 32 randomized controlled trials involving 2,434 patients with COPD found that Traditional Chines…
Traditional Chinese Exercise helps COPD patients walk further, breathe easier, and feel less anxious or depressed, according to a review of …
Apr 6, 2026
Allergy & Immunology
Sys. Review
FOXA transcription factors modulate epithelial integrity and inflammation in allergic asthma models
Review explores how FOXA proteins may influence asthma and allergic airway disease
A systematic review examines the role of FOXA transcription factors in allergic airway disease.
In healthy lungs, FOXA proteins keep airways stable, but allergic reactions shift these levels to worsen inflammation and airway changes.
Frontiers
Apr 6, 2026
Infectious Disease
First locally acquired hantavirus pulmonary syndrome case confirmed in Denver patient
A rare, serious lung virus was found in Denver. What does that mean?
A case report describes the first confirmed, apparently locally acquired case of hantavirus pulmonary syndrome in a patient from Denver, Col…
In 2018, Denver confirmed its first case of a rare lung infection carried by rodents, prompting health officials to stay alert.
CDC
Apr 6, 2026
Radiology & Imaging
RCT
EIT-guided PEEP titration improves oxygenation and respiratory mechanics in lateral decubitus laparoscopic surgery
Guided breathing support improved oxygen levels during side-position surgery in small trial
A randomized controlled trial of 71 adults undergoing urologic laparoscopic surgery in lateral decubitus found EIT-guided decremental PEEP t…
A new breathing support method kept oxygen levels higher and reduced lung pressure during side-lying surgery, though it did not lower post-o…
Apr 4, 2026
Neurology
Cohort
Retrospective study finds variation in COPD exacerbation care between respiratory and internal medicine
Does your hospital specialty affect your COPD care? A new study finds variation
A retrospective cohort study of 6,277 adults hospitalized for COPD exacerbations found variation in investigations and treatment practices b…
Hospital specialty matters for COPD care, as a new study shows different treatments for patients admitted to respiratory medicine versus int…
Frontiers
Apr 4, 2026